| Ms Jennifer M Jackson, AA | |
|
3000 Arlington Ave, Anesthesia, Toledo, OH 43614-2595 | |
| (419) 383-3556 | |
| (419) 383-3550 |
| Full Name | Ms Jennifer M Jackson |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology Assistant |
| Experience | 21 Years |
| Location | 3000 Arlington Ave, Toledo, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427042357 | NPI | - | NPPES |
| 2405050 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | 67000101 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Toledo Medical Center | Toledo, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Toledo Physicians Llc | 8729983416 | 315 |
News Archive
As the COVID-19 crisis continues to develop, researchers around the world are attempting to find the most effective treatment to combat the poorly understood virus behind this disease.
Two-thirds of women who donated eggs to fertility clinics reported satisfaction with the process, but 16 percent complained of subsequent physical symptoms and 20 percent reported lasting psychological effects, according to the first study to examine the long-term effects of donation.
ImmuneRegen BioSciences Inc.®, a wholly owned subsidiary of IR Biosciences Holdings Inc. (OTCBB: IRBS), today announced the execution of an agreement with the National Institute of Health (NIH) / National Cancer Institute (NCI) to commence studies utilizing ImmuneRegen's Homspera.
Clinical trials start this week for a stroke drug initially created by a team led by scientists at The Scripps Research Institute and the University of Southern California (USC), and further developed by biotech company ZZ Biotech.
CARMAT, the designer and developer of the world's most advanced artificial heart, today announced that it has completed the assembly of the first clinical version of its artificial heart (to be implanted in humans during clinical trials scheduled for 2011).
› Verified 1 days ago
| Entity Name | University Of Toledo Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942296033 PECOS PAC ID: 8729983416 Enrollment ID: O20031205000019 |
News Archive
As the COVID-19 crisis continues to develop, researchers around the world are attempting to find the most effective treatment to combat the poorly understood virus behind this disease.
Two-thirds of women who donated eggs to fertility clinics reported satisfaction with the process, but 16 percent complained of subsequent physical symptoms and 20 percent reported lasting psychological effects, according to the first study to examine the long-term effects of donation.
ImmuneRegen BioSciences Inc.®, a wholly owned subsidiary of IR Biosciences Holdings Inc. (OTCBB: IRBS), today announced the execution of an agreement with the National Institute of Health (NIH) / National Cancer Institute (NCI) to commence studies utilizing ImmuneRegen's Homspera.
Clinical trials start this week for a stroke drug initially created by a team led by scientists at The Scripps Research Institute and the University of Southern California (USC), and further developed by biotech company ZZ Biotech.
CARMAT, the designer and developer of the world's most advanced artificial heart, today announced that it has completed the assembly of the first clinical version of its artificial heart (to be implanted in humans during clinical trials scheduled for 2011).
› Verified 1 days ago
| Entity Name | Southwest Anesthesia Services Psc, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235188129 PECOS PAC ID: 3779483631 Enrollment ID: O20040109000000 |
News Archive
As the COVID-19 crisis continues to develop, researchers around the world are attempting to find the most effective treatment to combat the poorly understood virus behind this disease.
Two-thirds of women who donated eggs to fertility clinics reported satisfaction with the process, but 16 percent complained of subsequent physical symptoms and 20 percent reported lasting psychological effects, according to the first study to examine the long-term effects of donation.
ImmuneRegen BioSciences Inc.®, a wholly owned subsidiary of IR Biosciences Holdings Inc. (OTCBB: IRBS), today announced the execution of an agreement with the National Institute of Health (NIH) / National Cancer Institute (NCI) to commence studies utilizing ImmuneRegen's Homspera.
Clinical trials start this week for a stroke drug initially created by a team led by scientists at The Scripps Research Institute and the University of Southern California (USC), and further developed by biotech company ZZ Biotech.
CARMAT, the designer and developer of the world's most advanced artificial heart, today announced that it has completed the assembly of the first clinical version of its artificial heart (to be implanted in humans during clinical trials scheduled for 2011).
› Verified 1 days ago
| Entity Name | Ohio Anesthesia Group, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639348113 PECOS PAC ID: 9537222138 Enrollment ID: O20090108000069 |
News Archive
As the COVID-19 crisis continues to develop, researchers around the world are attempting to find the most effective treatment to combat the poorly understood virus behind this disease.
Two-thirds of women who donated eggs to fertility clinics reported satisfaction with the process, but 16 percent complained of subsequent physical symptoms and 20 percent reported lasting psychological effects, according to the first study to examine the long-term effects of donation.
ImmuneRegen BioSciences Inc.®, a wholly owned subsidiary of IR Biosciences Holdings Inc. (OTCBB: IRBS), today announced the execution of an agreement with the National Institute of Health (NIH) / National Cancer Institute (NCI) to commence studies utilizing ImmuneRegen's Homspera.
Clinical trials start this week for a stroke drug initially created by a team led by scientists at The Scripps Research Institute and the University of Southern California (USC), and further developed by biotech company ZZ Biotech.
CARMAT, the designer and developer of the world's most advanced artificial heart, today announced that it has completed the assembly of the first clinical version of its artificial heart (to be implanted in humans during clinical trials scheduled for 2011).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Jennifer M Jackson, AA 3355 Glendale Ave, Third Floor, Toledo, OH 43614-2426 Ph: (419) 383-7100 | Ms Jennifer M Jackson, AA 3000 Arlington Ave, Anesthesia, Toledo, OH 43614-2595 Ph: (419) 383-3556 |
News Archive
As the COVID-19 crisis continues to develop, researchers around the world are attempting to find the most effective treatment to combat the poorly understood virus behind this disease.
Two-thirds of women who donated eggs to fertility clinics reported satisfaction with the process, but 16 percent complained of subsequent physical symptoms and 20 percent reported lasting psychological effects, according to the first study to examine the long-term effects of donation.
ImmuneRegen BioSciences Inc.®, a wholly owned subsidiary of IR Biosciences Holdings Inc. (OTCBB: IRBS), today announced the execution of an agreement with the National Institute of Health (NIH) / National Cancer Institute (NCI) to commence studies utilizing ImmuneRegen's Homspera.
Clinical trials start this week for a stroke drug initially created by a team led by scientists at The Scripps Research Institute and the University of Southern California (USC), and further developed by biotech company ZZ Biotech.
CARMAT, the designer and developer of the world's most advanced artificial heart, today announced that it has completed the assembly of the first clinical version of its artificial heart (to be implanted in humans during clinical trials scheduled for 2011).
› Verified 1 days ago
Joshua Lynn Jay, CAA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 3000 Arlington Ave, Toledo, OH 43614 Phone: 419-383-3556 | |
Kera Sparks, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 4235 Secor Rd, Toledo, OH 43623 Phone: 419-473-3561 | |
Andrew Mccray, Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 3000 Arlington Ave, Toledo, OH 43614 Phone: 419-383-4000 | |
Brienne N Seekford, CAA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 3000 Arlington Ave, Toledo, OH 43614 Phone: 419-383-3888 Fax: 419-383-2860 | |
Jonathan Daniel Cox, AA-C Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 3000 Arlington Ave, Mailstop #1137, Toledo, OH 43614 Phone: 419-383-3556 Fax: 419-383-3550 | |
Mr. Jacob Kanjuparamban, A.A. Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 3000 Arlington Ave, Toledo, OH 43614 Phone: 419-383-3556 Fax: 419-383-3550 | |
Mr. Patrick Bolger, A.A. Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 3000 Arlington Ave, Toledo, OH 43614 Phone: 419-383-3556 Fax: 419-353-3550 |